| [1] |
Mosayyebi A, Vijayakumar A, Yue QY, et al. Engineering solutions to ureteral stents: material, coating and design[J]. Cent European J Urol, 2017, 70(3): 270-274.
|
| [2] |
Zhao J, Cao Z, Ren L, et al. A novel ureteral stent material with antibacterial and reducing encrustation properties[J]. Mater Sci Eng C Mater Biol Appl, 2016, 68: 221-228.
|
| [3] |
何朝辉, 王航涛, 唐福才, 等. 长期留置输尿管内支架对肾功能的影响[J]. 广州医科大学学报, 2017, 45(1): 32-35.
|
| [4] |
覃斌, 吴清国, 季汉初, 等. 上尿路双J管长期滞留合并结石治疗方法的选择[J]. 中国微创外科杂志, 2018, 18(8): 767-768.
|
| [5] |
林长明, 侯冰冰, 古宏兵, 等. 遗忘双J管自然断裂2例[J]. 临床泌尿外科杂志, 2019, 34(4): 332-333.
|
| [6] |
Khoddami S, Chew BH, Lange D. Problems and solutions of stent biofilm and encrustations: a review of literature[J]. Turk J Urol, 2020, 46(Supp. 1): S11-S18.
|
| [7] |
Small AC, Thorogood SL, Shah O, et al. Emerging mobile platforms to aid in stone management[J]. Urol Clin North Am, 2019, 46(2): 287-301.
|
| [8] |
Cao Z, Zhao J, Yang K. Cu-bearing stainless steel reduces cytotoxicity and crystals adhesion after ureteral epithelial cells exposing to calcium oxalate monohydrate[J]. Sci Rep, 2018, 8(1): 14094.
|
| [9] |
Lange D, Bidnur S, Hoag N, et al. Ureteral stent-associated complications-where we are and where we are going[J]. Nat Rev Urol, 2015, 12(1): 17-25.
|
| [10] |
Bai F, Cai Z, Yang L. Recent progress in experimental and human disease-associated multi-species biofilms[J]. Comput Struct Biotechnol J, 2019, 17: 1234-1244.
|
| [11] |
Yu Tsukanov A, Akhmetov DS, Blesman AI, et al. The impact of ureteral stent surface on encrustation and biofilm formation[J]. Urologiia, 2018(2): 40-45.
|
| [12] |
Roy R, Tiwari M, Donelli G, et al. Strategies for combating bacterial biofilms: a focus on anti-biofilm agents and their mechanisms of action[J]. Virulence, 2018, 9(1): 522-554.
|
| [13] |
de Grazia A, Somani BK, Soria F, et al. Latest advancements in ureteral stent technology[J]. Transl Androl Urol, 2019, 8(Suppl 4): S436-S441.
|
| [14] |
Zumstein V, Betschart P, Albrich WC, et al. Biofilm formation on ureteral stents - incidence, clinical impact, and prevention[J]. Swiss Med Wkly, 2017, 147: w14408.
|
| [15] |
Chew BH, Chan J, Choy D, et al. The interaction of urinary components with biomaterials in the urinary tract: ureteral stent discoloration[J]. J Endourol, 2020, 34(5): 608-616.
|
| [16] |
Toprak T, Şahin A, Kutluhan MA, et al. Does duration of stenting increase the risk of clinical infection?[J]. di, 2020, 91(4): 237-240.
|
| [17] |
Kartal I G, Baylan B, Gok A, et al. The association of encrustation and ureteral stent indwelling time in urolithiasis and KUB grading system[J]. Urol J, 2018, 15(6): 323-328.
|
| [18] |
Shabeena KS, Bhargava R, Manzoor MAP, et al. Characteristics of bacterial colonization after indwelling double-J ureteral stents for different time duration[J]. Urol Ann, 2018, 10(1): 71-75.
|
| [19] |
Zampini A, Nguyen AH, Rose E, et al. Defining dysbiosis in patients with urolithiasis[J]. Sci Rep, 2019, 9(1): 5425.
|
| [20] |
Buhmann MT, Abt D, Nolte O, et al. Encrustations on ureteral stents from patients without urinary tract infection reveal distinct urotypes and a low bacterial load[J]. Microbiome, 2019, 7(1): 60.
|
| [21] |
Li X, Gao H, Sun X, et al. A preliminary study on the role of Bacteroides fragilis in stent encrustation[J]. World J Urol, 2021, 39(2): 579-588.
|
| [22] |
Beysens M, Tailly TO. Ureteral stents in urolithiasis[J]. Asian J Urol, 2018, 5(4): 274-286.
|
| [23] |
Kawahara T, Ito H, Terao H, et al. Ureteral stent encrustation, incrustation, and coloring: morbidity related to indwelling times[J]. J Endourol, 2012, 26(2): 178-182.
|
| [24] |
Forbes C, Scotland KB, Lange D, et al. Innovations in ureteral stent technology[J]. Urol Clin North Am, 2019, 46(2): 245-255.
|
| [25] |
Rebl H, Renner J, Kram W, et al. Prevention of encrustation on ureteral stents: which surface parameters provide guidance for the development of novel stent materials?[J]. Polymers, 2020, 12(3): 558.
|
| [26] |
Cottone CM, Lu S, Wu YX, et al. Surface-treated pellethanes: comparative quantification of encrustation in artificial urine solution[J]. J Endourol, 2020, 34(8): 868-873.
|
| [27] |
El-Nahas AR, Lachine M, Elsawy E, et al. A randomized controlled trial comparing antimicrobial (silver sulfadiazine)-coated ureteral stents with non-coated stents[J]. Scand J Urol, 2018, 52(1): 76-80.
|
| [28] |
Szell T, Dressler FF, Goelz H, et al. In vitro effects of a novel coating agent on bacterial biofilm development on ureteral stents[J]. J Endourol, 2019, 33(3): 225-231.
|
| [29] |
Ahmed EM. Hydrogel: preparation, characterization, and applications: a review[J]. J Adv Res, 2015, 6(2): 105-121.
|
| [30] |
Singha P, Locklin J, Handa H. A review of the recent advances in antimicrobial coatings for urinary catheters[J]. Acta Biomater, 2017, 50: 20-40.
|
| [31] |
Gadzhiev N, Gorelov D, Malkhasyan V, et al. Comparison of silicone versus polyurethane ureteral stents: a prospective controlled study[J]. BMC Urol, 2020, 20(1): 10.
|
| [32] |
Tian Q, Zhang C, Deo M, et al. Responses of human urothelial cells to magnesium-zinc-strontium alloys and associated insoluble degradation products for urological stent applications[J]. Mater Sci Eng C Mater Biol Appl, 2019, 96: 248-262.
|
| [33] |
Champagne S, Mostaed E, Safizadeh F, et al. In vitro degradation of absorbable zinc alloys in artificial urine[J]. Materials, 2019, 12(2): 295.
|
| [34] |
Asakawa J, Iguchi T, Tamada S, et al. Treatment outcomes of ureteral stenting for malignant extrinsic ureteral obstruction: a comparison between polymeric and metallic stents[J]. Cancer Manag Res, 2018, 10: 2977-2982.
|
| [35] |
Zhao J, Cao Z, Lin H, et al. In vivo research on Cu-bearing ureteral stent[J]. J Mater Sci Mater Med, 2019, 30(7): 83.
|
| [36] |
Barros AA, Oliveira C, Ribeiro AJ, et al. In vivo assessment of a novel biodegradable ureteral stent[J]. World J Urol, 2018, 36(2): 277-283.
|
| [37] |
Chew BH, Lange D, Paterson RF, et al. Next generation biodegradable ureteral stent in a yucatan pig model[J]. J Urol, 2010, 183(2): 765-771.
|
| [38] |
肖世伟, 李亚楠, 刘军, 等. 可降解输尿管支架管的研究进展[J]. 中华泌尿外科杂志, 2018, 39(1): 76-78.
|
| [39] |
Mosayyebi A, Lange D, Yann Yue Q, et al. Reducing deposition of encrustation in ureteric stents by changing the stent architecture: a microfluidic-based investigation[J]. Biomicrofluidics, 2019, 13(1): 014101.
|
| [40] |
Novikov AA, Tsukanov AY, Akhmetov DS, et al. Noninvasive ultrasonic sanitation of stents for drainage of the upper urinary tract[J]. Biomed Eng, 2018, 52(3): 173-176.
|
| [41] |
Ordonez M, Hwang EC, Borofsky M, et al. Ureteral stent versus no ureteral stent for ureteroscopy in the management of renal and ureteral calculi[J]. Cochrane Database Syst Rev, 2019, 2(2): CD012703.
|
| [42] |
Acosta-Miranda AM, Milner J, Turk TMT. The FECal Double-J: a simplified approach in the management of encrusted and retained ureteral stents[J]. J Endourol, 2009, 23(3): 409-415.
|
| [43] |
Arenas JL, Shen JK, Keheila M, et al. Kidney, ureter, and bladder (KUB): a novel grading system for encrusted ureteral stents[J]. Urology, 2016, 97: 51-55.
|
| [44] |
Wollin DA, Joyce AD, Gupta M, et al. Antibiotic use and the prevention and management of infectious complications in stone disease[J]. World J Urol, 2017, 35(9): 1369-1379.
|
| [45] |
Lee JH, Muthukumar T, Kim J, et al. Antibiotic prophylaxis for ureteral stent removal after kidney transplantation[J]. Clin Transplant, 2019, 33(3): e13491.
|
| [46] |
Rosado-Canto R, Parra-Avila I, Tejeda-Maldonado J, et al. Perioperative fosfomycin disodium prophylaxis against urinary tract infection in renal transplant recipients: a randomized clinical trial[J]. Nephrol Dial Transplant, 2020, 35(11): 1996-2003.
|
| [47] |
Alenezi NA, Zanaty F, Hodhod A, et al. The safety of ureteral stenting with the use of potassium citrate for management of renal uric acid stones[J]. Urol Ann, 2020, 12(1): 37-41.
|
| [48] |
周腾春, 耿志勇, 陈广进. 双J管拔除困难常见原因分析[J]. 临床和实验医学杂志, 2012, 11(4): 297-298.
|